Skip to main content
. 2019 Jan 4;9:1138. doi: 10.3389/fneur.2018.01138

Table 1.

The vHIT gains mean (range) collected with visible target and in darkness in the BVL group of 17 patients.

Patient vHIT gAINS
Visible target Darkness
Left Right Left Right
1 0.59 (0.55–0.64) 0.39 (0.21–0.64) 0.59 (0.32–0.68) 0.31 (0.11–0.56)
2 0.24 (0.12–0.41) 0.27 (0.19–0.31) 0.35 (0.07–0.46) 0.22 (0.12–0.35)
3 0.49 (0.42–0.72) 0.69 (0.57–0.73) 0.43 (0.24–0.73) 0.58 (0.4–0.83)
4 0.58 (0.16–0.67) 0.49 (0.11–0.61) 0.61 (0.06–0.9) 0.44 (0–0.54)
5 0.16 (0.07–0.34) 0.12 (0–0.26) 0.18 (0–0.41) 0.14 (0–0.25)
6 0.30 (0.19–0.69) 0.17 (0.11–0.27) 0.22 (0–0.61) 0.27 (0.06–0.56)
7 0.58 (0.06–0.78) 0.30 (0.15–0.45) 0.28 (0.03–0.6) 0.32 (0.23–0.44)
8 0.08 (0–0.2) 0.17 (0.1–0.28) 0.07 (0–0.26) 0.10 (0–0.2)
9 0.16 (0.03–0.39) 0.22 (0.15–0.27) 0.11 (0–0.43) 0.16 (0–0.3)
10 0.40 (0.15–0.45) 0.35 (0–0.76) 0.34 (0.13–0.5) 0.27 (0.14–0.36)
11 0.17 (0.1–0.34) 0.25 (0.01–0.38) 0.17 (0.15–0.19) 0.24 (0.13–0.28)
12 0.16 (0.05–0.57) 0.19 (0–0.63) 0.29 (0–0.56) 0.17 (0–0.6)
13 0.52 (0.22–0.69) 0.50 (0.23–0.62) 0.51 (0.2–0.61) 0.48 (0.21–0.61)
14 0.28 (0.19–0.48) 0.30 (0.19–0.91) 0.23 (0.12–0.73) 0.14 (0–0.31)
15 0.32 (0.08–0.5) 0.79 (0.09–0.94) 0.28 (0.14–0.58) −0.12 (0–0.63)
16 0.11 (0.09–0.16) 0.14 (0.1–0.24) 0.35 (0.08–0.69) 0.33 (0.12–0.55)
17 0.14 (0.09–0.18) 0.22 (0.17–0.27) 0.09 (0–0.14) 0.20 (0.09–0.38)